Phi Optics, a Serra Capital I portfolio company, was featured on the University of Illinois Engineering news website on November 3. Phi Optics has created a light microscopy device with label-free, non-invasive, quantitative, nanoscale, 3D tomographic and real-time information capabilities.

The article claims that Phi Optics has a “new optical method promising more accurate diagnosis and prognosis for cancer patients” and further explains the benefits and details of the technology – which includes the breakthrough ability for determining if tissue is cancerous or not.